Follow
Willem Adriaan de Jongh
Willem Adriaan de Jongh
Stellenbosch, ExpreS2ion, DTU, Copenhagen university, danish technical university
Verified email at expres2ionbio.com
Title
Cited by
Cited by
Year
Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies
KE Wright, KA Hjerrild, J Bartlett, AD Douglas, J Jin, RE Brown, ...
Nature 515 (7527), 427-430, 2014
2052014
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
S Thrane, CM Janitzek, S Matondo, M Resende, T Gustavsson, ...
Journal of nanobiotechnology 14, 1-16, 2016
2032016
First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria
B Mordmüller, M Sulyok, D Egger-Adam, M Resende, WA de Jongh, ...
Clinical Infectious Diseases 69 (9), 1509-1516, 2019
1262019
Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies
DGW Alanine, D Quinkert, R Kumarasingha, S Mehmood, FR Donnellan, ...
Cell 178 (1), 216-228. e21, 2019
1152019
Virus-like particle display of HER2 induces potent anti-cancer responses
A Palladini, S Thrane, CM Janitzek, J Pihl, SB Clemmensen, ...
Oncoimmunology 7 (3), e1408749, 2018
1022018
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
RO Payne, SE Silk, SC Elias, KH Milne, TA Rawlinson, D Llewellyn, ...
JCI insight 2 (12), 2017
992017
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
AM Minassian, SE Silk, JR Barrett, CM Nielsen, K Miura, A Diouf, C Loos, ...
Med 2 (6), 701-719. e19, 2021
962021
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
C Fougeroux, L Goksøyr, M Idorn, V Soroka, SK Myeni, R Dagil, ...
Nature Communications 12 (1), 324, 2021
872021
Enhanced citrate production through gene insertion in Aspergillus niger
WA De Jongh, J Nielsen
Metabolic engineering 10 (2), 87-96, 2008
862008
Structure of Plasmodium falciparum Rh5–CyRPA–Ripr invasion complex
W Wong, R Huang, S Menant, C Hong, JJ Sandow, RW Birkinshaw, ...
Nature 565 (7737), 118-121, 2019
812019
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system
KA Hjerrild, J Jin, KE Wright, RE Brown, JM Marshall, GM Labbé, SE Silk, ...
Scientific reports 6 (1), 30357, 2016
672016
Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal ‘C-tag’
J Jin, KA Hjerrild, SE Silk, RE Brown, GM Labbé, JM Marshall, KE Wright, ...
International journal for parasitology 47 (7), 435-446, 2017
652017
The roles of galactitol, galactose‐1‐phosphate, and phosphoglucomutase in galactose‐induced toxicity in Saccharomyces cerevisiae
WA de Jongh, C Bro, S Ostergaard, B Regenberg, L Olsson, J Nielsen
Biotechnology and bioengineering 101 (2), 317-326, 2008
642008
Vacuum pyrolysis of intruder plant biomasses
WA De Jongh, M Carrier, JHH Knoetze
Journal of Analytical and Applied Pyrolysis 92 (1), 184-193, 2011
622011
Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells
J Jin, RD Tarrant, EJ Bolam, P Angell-Manning, M Soegaard, ...
npj Vaccines 3 (1), 32, 2018
532018
The influence of sub-unit composition and expression system on the functional antibody response in the development of a VAR2CSA based Plasmodium falciparum placental malaria …
MA Nielsen, M Resende, WA de Jongh, SB Ditlev, B Mordmüller, ...
PLoS One 10 (9), e0135406, 2015
522015
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes
J Healer, W Wong, JK Thompson, W He, RW Birkinshaw, K Miura, ...
Cellular microbiology 21 (7), e13030, 2019
432019
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
F Lennartz, F Brod, R Dabbs, K Miura, D Mekhaiel, A Marini, MM Jore, ...
Nature communications 9 (1), 3822, 2018
332018
The use of Drosophila S2 cells in R&D and bioprocessing
W Adriaan de Jongh, S Salgueiro, C Dyring
Pharmaceutical Bioprocessing 1 (2), 197-213, 2013
312013
Two-component nanoparticle vaccine displaying glycosylated spike S1 domain induces neutralizing antibody response against SARS-CoV-2 variants
L van Oosten, JJ Altenburg, C Fougeroux, C Geertsema, F van den End, ...
MBio 12 (5), 10.1128/mbio. 01813-21, 2021
302021
The system can't perform the operation now. Try again later.
Articles 1–20